Sugi Predict

Sugi Predict / Compounds / SCHEMBL2883804

SCHEMBL2883804

SCHEMBL2883804

Cc1cccc(-c2nc(-c3ccc(-c4ccccc4)cc3)nc(-c3ccc(-c4ccccc4)cc3)n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 7/20 0.61
▸ L3MBTL1 Q9Y468 4/20 0.57
▸ NR1I3 Q14994 1/20 0.55
▸ DPP4 P27487 1/20 0.54
▸ NPC1 O15118 6/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ MAPT P10636 3/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ ABCB1 P08183 1/20 0.49
▸ ABCG2 Q9UNQ0 1/20 0.49
▸ TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2876330 1.00 RAB9A (0.61) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL16376446 1.00 RAB9A (0.61) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL19037188 1.00 RAB9A (0.61) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL17051681 0.96 RAB9A (0.58) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL18267907 0.96 RAB9A (0.58) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL19007466 0.96 RAB9A (0.58) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL23763299 0.96 L3MBTL1 (0.57) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL18267901 0.96 L3MBTL1 (0.57) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL10330371 0.96 L3MBTL1 (0.57) RAB9AL3MBTL1NR1I3DPP4NPC1
SCHEMBL4546946 0.96 L3MBTL1 (0.57) RAB9AL3MBTL1NR1I3DPP4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773320-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-03 — — US disclosed
US-11773320-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-03 — — US disclosed
US-11031560-B2 Compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-06-08 — — US disclosed
US-10800969-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-10-13 — — US disclosed
US-20200274076-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2020-08-27 — — US disclosed
US-10730812-B2 Double spiro compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2020-08-04 — — US disclosed
US-10651411-B2 Compound and organic light emitting device containing same LG CHEM, LTD. (KR) 2020-05-12 — — US disclosed
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 — — US disclosed
US-20180148641-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 — — US disclosed
US-20180148641-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 — — US disclosed
US-20080199726-A1 Electroluminescent Device CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2008-08-21 — — US disclosed
EP-1743011-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-01-17 — — EP disclosed
US-20060251920-A1 Organic light emitting devices comprising a doped triazine electron transport layer XEROX CORPORATION 2006-11-09 — — US disclosed
US-20060251919-A1 Organic light emitting devices XEROX CORPORATION 2006-11-09 — — US disclosed
US-20060135766-A1 Electroluminescent device CIBA SPECIALTY CHEMICALS CORP. 2006-06-22 — — US disclosed
EP-1597938-A2 ELECTROLUMINESCENT DEVICE Ciba SC Holding AG (CH) 2005-11-23 — — EP disclosed
WO-2005105950-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-10 — — WO disclosed
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 — — US disclosed
WO-2004077885-A2 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-09-10 — — WO disclosed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135766-A1 Electroluminescent device TAAR5, TYR, TRPC5 RAB9A 3537/4885L3MBTL1 1776/4885NR1I3 2478/4885
US-11773320-B2 Organic electroluminescent materials and devices CCNL2, HCN4, HNRNPL RAB9A 2154/4885L3MBTL1 113/4885NR1I3 792/4885
US-11031560-B2 Compound and organic electronic element comprising same OR10J3, ESR1, ETV6 RAB9A 3275/4885L3MBTL1 3030/4885NR1I3 2777/4885
US-10800969-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 RAB9A 2886/4885L3MBTL1 720/4885NR1I3 558/4885
US-20200274076-A1 Organic Electroluminescent Materials and Devices CCNL2, HCN4, HNRNPL RAB9A 2140/4885L3MBTL1 117/4885NR1I3 763/4885
US-10651411-B2 Compound and organic light emitting device containing same CRY1, CRY2, OR10J3 RAB9A 3113/4885L3MBTL1 349/4885NR1I3 912/4885
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 RAB9A 2518/4885L3MBTL1 856/4885NR1I3 633/4885
US-20180148641-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 RAB9A 3107/4885L3MBTL1 962/4885NR1I3 624/4885
US-20080199726-A1 Electroluminescent Device TPMT, THPO, KYNU RAB9A 4428/4885L3MBTL1 1449/4885NR1I3 3409/4885
US-10730812-B2 Double spiro compound and organic light-emitting element comprising same NR2E3, CRY1, CRY2 RAB9A 2549/4885L3MBTL1 2738/4885NR1I3 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.